Navigation Links
American Investors Highlight Successes in Eastern Germany
Date:6/12/2009

CHICAGO, June 12 /PRNewswire/ -- Germany remains an attractive investment location for North American companies, driven by the eastern federal states. This is in large part due to the robust high-tech industries and continuing growth potential despite the economic crisis. American investor interest in Germany remains steady, as confirmed by recent studies. Minneapolis-based Despatch Industries and Nordex AG shared their success stories at the "How Far East? Eastern Germany: The No. 1 Business Location for US Investment Success" road show organized by Germany Trade & Invest in Chicago last night.

There are around 6,000 American companies with over 700,000 employees located in Germany. These companies are active in all major industries. Investor interest has concentrated heavily on growth sectors that are based primarily in Eastern Germany. These include the robust IT, healthcare, and renewable energies branches. The recent Ernst & Young European Attractiveness Survey supports this: Germany was again the number one investment location in Europe for international managers.

Patrick J. Peyton, Chairman/CEO of Despatch Industries, outlined his company's success, highlighting the benefits of doing business in Eastern Germany. Despatch is a leading thermal processing equipment supplier. A driver for the company's achievements, Peyton argued, was the competitive advantage obtained by the region's cutting edge high-tech industries.

Peyton said: "Europe and the Middle East represent growing and strategic markets for our business activities and Berlin as a central location in Europe, with close proximity to our global partners and major customer centers, was the best decision."

Jorg Scholle, Head of Global Production for Nordex AG, a global leader in the wind energy industry, also detailed the company's successes in Germany. Driven by the eastern federal states, Germany is a global
'/>"/>

SOURCE Germany Trade and Invest
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. American Lung Association in Iowa Thanks Senators Harkin and Grassley for Votes to Pass Legislation Granting FDA Authority Over Tobacco Products
2. Statement by American Heart Association CEO Nancy Brown on Senate Passage of the Family Smoking Prevention and Tobacco Control Act June 11, 2009
3. New American College of Surgeons risk calculator determines colorectal surgery risk
4. 12th Annual Health Confidence Survey: Americans Show Support for Several Health Coverage Options, But Their Views Could Change as More Details Emerge
5. American Otological Society 2009 Recipient For the "Award of Merit" Goes to Dr. William H. Lippy of Warren, Ohio
6. Founder of Snoring Isn't Sexy, LLC Addresses Annual Meeting of the American Academy of Dental Sleep Medicine
7. Americans United for Life Action Says the House-Approved Bill to Promote Abortion Overseas is a Grave Injustice
8. Statement by American Dietetic Association Supporting Scientifically Valid, Informative Restaurant Labeling as Part of Health Reform
9. Daisy Brand(R) Cottage Cheese Invites Americans to Freshen Up Your Fridge
10. Latest trinational report presents most complete picture of North American industrial pollution
11. American Academy of Pediatric Dentistry Releases New Perinatal and Infant Oral Health Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group 2Health News:DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group 3Health News:SXC Health Solutions announces informedRx renewal contract with The University of Michigan 2Health News:Samplify Systems Announces Distribution Agreement With Tokyo Electron Device Limited, Broadening Availability of Signal Compression Technology 2Health News:Breastfeeding.com Launches First Ever Social Network for Birth-Related Medical Professionals 2Health News:Womenshealthchannel Enhancements Support Pregnant Teens 2Health News:Womenshealthchannel Enhancements Support Pregnant Teens 3Health News:Womenshealthchannel Enhancements Support Pregnant Teens 4Health News:Womenshealthchannel Enhancements Support Pregnant Teens 5Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 2Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 3Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 4Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 5
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New Evidence Supports HPV Vaccine 50832 1New Evidence Supports HPV Vaccine 50832 2Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 1Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 2Carbohydrate acts as tumor suppressor 50828 1Carbohydrate acts as tumor suppressor 50828 2